GW Pharmaceuticals PLC (NASDAQ:GWPH)

122.93
Delayed Data
As of May 29
 -2.53 / -2.02%
Today’s Change
67.98
Today|||52-Week Range
182.05
+17.57%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$3.8B

Company Description

GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.

Contact Information

GW Pharmaceuticals Plc
Sovereign House
Cambridge Cambridgeshire CB24 9BZ
P:441223266800
Investor Relations:
(917) 280-2424

Employees

Shareholders

Mutual fund holders58.88%
Other institutional24.68%
Individual stakeholders--

Top Executives

There are no executives to display.